Suppr超能文献

肿瘤基因治疗的进展与展望

Advancement and prospects of tumor gene therapy.

作者信息

Zhang Chao, Wang Qing-Tao, Liu He, Zhang Zhen-Zhu, Huang Wen-Lin

机构信息

Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.

出版信息

Chin J Cancer. 2011 Mar;30(3):182-8. doi: 10.5732/cjc.010.10074.

Abstract

Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. Several therapeutic strategies have evolved, including gene-based (tumor suppressor genes, suicide genes, antiangiogenic genes, cytokine and oxidative stress-based genes) and RNA-based (antisense oligonucleotides and RNA interference) approaches. In addition, immune response-based strategies (dendritic cell- and T cell-based therapy) are also under investigation in tumor gene therapy. This review highlights the progress and recent developments in gene delivery systems, therapeutic strategies, and possible clinical directions for gene therapy.

摘要

基因治疗是肿瘤治疗中最具吸引力的领域之一。在过去几十年里,已经取得了重大进展。人们开发了各种方法,如病毒载体和非病毒载体以及物理方法,以使基因传递更安全、更有效。几种治疗策略也得到了发展,包括基于基因的(肿瘤抑制基因、自杀基因、抗血管生成基因、细胞因子和基于氧化应激的基因)和基于RNA的(反义寡核苷酸和RNA干扰)方法。此外,基于免疫反应的策略(基于树突状细胞和T细胞的治疗)也正在肿瘤基因治疗中进行研究。本综述重点介绍了基因传递系统、治疗策略以及基因治疗可能的临床方向的进展和最新发展情况。

相似文献

1
Advancement and prospects of tumor gene therapy.
Chin J Cancer. 2011 Mar;30(3):182-8. doi: 10.5732/cjc.010.10074.
2
Suicide gene therapy in cancer: where do we stand now?
Cancer Lett. 2012 Nov 28;324(2):160-70. doi: 10.1016/j.canlet.2012.05.023. Epub 2012 May 24.
3
Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.
Curr Gene Ther. 2012 Aug;12(4):275-84. doi: 10.2174/156652312802083576.
4
Viral-mediated gene transfer for cancer treatment.
Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. doi: 10.2174/1389201023378445.
5
Vector-mediated cancer gene therapy: an overview.
Cancer Biol Ther. 2005 May;4(5):512-7. doi: 10.4161/cbt.4.5.1705. Epub 2005 May 5.
6
Cancer suicide gene therapy: a patent review.
Expert Opin Ther Pat. 2016 Sep;26(9):1095-104. doi: 10.1080/13543776.2016.1211640. Epub 2016 Jul 20.
7
Vectors and strategies for nonviral cancer gene therapy.
Expert Opin Biol Ther. 2016;16(4):443-61. doi: 10.1517/14712598.2016.1134480. Epub 2016 Jan 13.
8
Cancer gene therapy by adenovirus-mediated gene transfer.
Curr Gene Ther. 2001 May;1(1):101-22. doi: 10.2174/1566523013349002.
9
Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies.
Curr Gene Ther. 2005 Dec;5(6):629-41. doi: 10.2174/156652305774964749.
10
Gene therapy for mesothelioma and lung cancer.
Am J Respir Cell Mol Biol. 2010 Apr;42(4):385-93. doi: 10.1165/rcmb.2010-0026RT. Epub 2010 Feb 16.

引用本文的文献

1
Lactylation in Tumor Immune Escape and Immunotherapy: Multifaceted Functions and Therapeutic Strategies.
Research (Wash D C). 2025 Sep 11;8:0793. doi: 10.34133/research.0793. eCollection 2025.
3
A Winning New Combination? Toward Clinical Application in Oncology.
Cancer Control. 2023 Jan-Dec;30:10732748231175240. doi: 10.1177/10732748231175240.
4
Adding recombinant AAVs to the cancer therapeutics mix.
Mol Ther Oncolytics. 2022 Oct 2;27:73-88. doi: 10.1016/j.omto.2022.09.009. eCollection 2022 Dec 15.
5
Ferroptosis-Inducing Nanomedicine for Cancer Therapy.
Front Pharmacol. 2021 Dec 20;12:735965. doi: 10.3389/fphar.2021.735965. eCollection 2021.
6
Tumor progression-dependent angiogenesis in gastric cancer and its potential application.
World J Gastrointest Oncol. 2019 Sep 15;11(9):686-704. doi: 10.4251/wjgo.v11.i9.686.
7
Tumor angiogenesis and anti-angiogenic gene therapy for cancer.
Oncol Lett. 2018 Jul;16(1):687-702. doi: 10.3892/ol.2018.8733. Epub 2018 May 17.
8
Effect of IL-17 in the development of colon cancer in mice.
Oncol Lett. 2016 Dec;12(6):4929-4936. doi: 10.3892/ol.2016.5329. Epub 2016 Oct 31.
9
Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2.
Cancer Gene Ther. 2016 Oct;23(10):341-347. doi: 10.1038/cgt.2016.37. Epub 2016 Sep 16.
10
Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation.
Oncol Lett. 2015 Jul;10(1):143-148. doi: 10.3892/ol.2015.3248. Epub 2015 May 20.

本文引用的文献

1
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer.
Gene Ther. 2010 Mar;17(3):360-9. doi: 10.1038/gt.2009.159. Epub 2009 Dec 24.
2
Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo.
Cell Biol Toxicol. 2010 Feb;26(1):21-8. doi: 10.1007/s10565-009-9144-8. Epub 2009 Dec 1.
4
Dendritic cell-based cancer gene therapy.
Hum Gene Ther. 2009 Oct;20(10):1106-18. doi: 10.1089/hum.2009.145.
5
Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
Expert Opin Drug Deliv. 2009 Jul;6(7):673-86. doi: 10.1517/17425240902992894.
7
The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Biomaterials. 2009 Aug;30(23-24):4014-20. doi: 10.1016/j.biomaterials.2009.04.011. Epub 2009 May 8.
8
Preclinical development of T cell receptor gene therapy.
Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25.
9
Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. doi: 10.1016/j.addr.2009.02.005. Epub 2009 Feb 26.
10
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
J Clin Oncol. 2008 Dec 20;26(36):5896-903. doi: 10.1200/JCO.2007.15.6794. Epub 2008 Nov 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验